News Snapshot:
June 30, 2022 SEOUL – South Korea has authorized its first homegrown COVID-19 vaccine, finally securing vaccine sovereignty almost 30 months after the pandemic began. The government on Wednesday announced the official approval of SKYCovione, a recombinant protein-based COVID-19 vaccine developed by SK Bioscience, after the final examination committee held a meeting to review the previous assessments earlier in the day. “The Ministry of Food and Drug Safety thoroughly verified safety and efficacy through a three-step consultative process and approved SK Bioscience’s SKYCovione,” said Oh Yu-kyoung, Minister of Food and Drug Safety. The Drug Ministry said it has decided to...
